lundi 01 juin 2020

CurePSP Foundation: Venture Grant Application

CurePSP provides “seed funding” to investigators who have innovative ideas that need “proof of concept” in order to qualify for larger funding sources.

CurePSP will fund studies on PSP and CBD with a particular interest in:

(i) molecular and cellular (pathological) mechanisms that may operate also in related diseases and

(ii) translational clinical research involving PSP and CBD patients.

We provide grants to scientists of up to $100,000 for one- or two-year studies.

Grant application extended deadlines: June 1, 2020

https://www.psp.org/iwanttolearn/grants/

mercredi 03 juin 2020

Partenariats public-privés pour la recherche contre le Covid-19

BPI France finance jusqu'à 50 millions d'euros des travaux de recherche et développement qui associent des industriels et leurs partenaires publics, dans le cadre de la lutte contre l'épidémie de Covid-19.

Ce programme propose de soutenir des projets collaboratifs de recherche et développement structurants visant le développement de solutions thérapeutiques à visée préventive ou curative contre le COVID-19. Des retombées économiques et technologiques directes sous forme de nouveaux produits, services et technologies, sont attendues. Toutes les stratégies thérapeutiques sont éligibles (vaccinales, antivirales, mixtes, etc.) ainsi que toutes les technologies (chimie, biotechnologie, intelligence artificielle et exploitation de données massives ou dispositif médical si pertinent).

Date limite de candidature 30 septembre 2020.
+ d'infos : https://www.bpifrance.fr/A-la-une/Appels-a-projets-concours/PSPC-COVID-19-49161

mercredi 03 juin 2020

L’ANR soutient les recherches à court terme sur le Covid-19

L'Agence nationale de la recherche lance un nouvel appel pour soutenir des projets de type recherche-action RA-Covid-19 dont les résultats pourraient être diffusés à la société dans les trois à douze prochains mois.

Pour assurer sa réactivité, cet appel qui prolonge l'appel Flash Covid-19, sera ouvert en continu jusqu'au 28 octobre 2020

Conformément aux recommandations de l'Organisation mondiale de la Santé, les thématiques de l'appel concernent :

• les études épidémiologiques,
• la physiopathogénie de la maladie,
• la prévention et contrôle de l'infection,
• l'éthique et dynamiques sociales,
• les enjeux globaux de l'épidémie Covid-19.

Pour permettre un financement rapide des propositions, la sélection sera opérée au fil de l'eau.

L'ouverture du site de dépôt des projets est prévue le 20 avril 2020.

https://intranet.inserm.fr/actualites/Pages/detail.aspx?news_id=301

https://anr.fr/fr/detail/call/appel-a-projets-ra-covid-19/

mercredi 03 juin 2020

DIM ELICIT: Special Call SARS-CoV-2

The DIM ELICIT would like to support projects developing innovative technologies and methods regarding the analysis, diagnosis and / or treatment to fight SARS-CoV-2.

Any research team from the region Ile de France can apply with a project linked to the infectious agent SARS-CoV-2, and in accordance with the DIM ELICIT’s goals, positioning and thematic axes.

In the context of this call, the DIM ELICIT will fund each project:

- 15k€ for running and / or staff costs

and / or

- 30k€ of equipment

(66% max of total cost without VAT).

The projects submitted must target the acquisition of knowledge with a potential impact expected within 18 months following the funding.

This call will be open until the end of the crisis.

We will acknowledge the receipt of the applications within two days and try to give you a feedback on your eligibility within a week.

For more information and the application form, please see the link:
Special call for proposals - Fight SARS-CoV-2

https://dim-elicit.fr/appels-a-projets/

For any further question, do not hesitate to contact:
axel.bonetto@pasteur.fr or dim.elicit@pasteur.fr

mercredi 10 juin 2020

Fondation Maladies Rares / Association Autour du BPAN : appel à projets

La Fondation Maladies Rares soutient l'appel à projets de l’association Autour du BPAN qui lance son 2nd appel à projets en faveur de la recherche fondamentale et la recherche clinique sur la neurodegénérescence liée à une mutation du gène WDR45 (BPAN – Beta-propeller Protein-Associated Neurodegeneration).
Montant : 30 000 €
Date limite de candidature : 10 juin 2020

https://fondation-maladiesrares.org/la-recherche/appel-a-projets-autour-du-bpan-2020/

jeudi 11 juin 2020

Covid-19 : appel à manifestation d'intérêt de la Commission européenne

Dans le cadre de la lutte contre l'épidémie de Covid-19, la Commission européenne ouvre les appels à projets ci-dessous.

Date limite de candidature : 11 juin 2020.
Contact Inserm 

• Repurposing of manufacturing for vital medical supplies and equipment
• Medical technologies, Digital Tools and Artificial Intellligence analytics to improve surveillance and care at high Technology Readiness Levels
• Behavioural, social and economic impacts of the outbreak response
• Pan-European COVID-19 cohorts united against the pandemics
• Networking of existing EU and international cohorts of relevance to Covid-19

mercredi 17 juin 2020

Fondation de France : Neuro-développement typique de l'enfant et autisme

En 2020, la Fondation de France décide de réaffirmer son soutien à ce champ de recherche, en considérant des projets d’envergure, innovants et collaboratifs, qui contribueront au progrès des connaissances sur :

• les bases cérébrales du développement cognitif et affectif typique (de la vie fœtale à la fin de l’adolescence) ;
• les mécanismes d’apprentissage de l’enfant au sens large, en particulier en milieu scolaire ;
• l’autisme.

• Ces aides peuvent être pluriannuelles (d’une durée maximale de trois ans).
• Elles peuvent notamment être destinées à l’accueil de chercheurs doctorants (financements pour trois ans maximum) et/ou post-doctorants (financements pour deux ans maximum).
• Les montants des financements accordés ne peuvent dépasser 250 000 € par projet collaboratif.

Date limite de dépôt des dossiers : 17 juin 2020

https://www.fondationdefrance.org/fr/recherche-clinique-et-fondamentale-sur-lautisme-et-le-neuro-developpement-de-lenfant

lundi 22 juin 2020

Innovative Medicines Initiative (IMI): IMI2 – Calls 22 and 23

Indicative future Call dates: IMI plans to launch IMI2 – Calls 22 and 23 on 23 June 2020. This date is indicative and may change.

The following topics are under consideration for inclusion in the next IMI Calls for proposals:

• Returning clinical trial data to study participants within a GDPR compliant and approved framework
• Modelling the impact of monoclonal antibodies and vaccines on the reduction of antimicrobial resistance. This topic is part of IMI’s Antimicrobial Resistance (AMR) Accelerator programme.
• A platform for accelerating biomarker discovery and validation to support therapeutics development for neurodegenerative diseases. https://www.imi.europa.eu/sites/default/files/uploads/documents/apply-for-funding/future-topics/DraftTopic_NeuroBiomarker_v6April.pdf
• Optimal treatment for patients with solid tumours in Europe through artificial intelligence
• Shortening the path to rare disease diagnosis by using new born genetic screening and digital technologies
• Behavioural model of factors affecting patient adherence
• Restricted Call to maximise impact of IMI2 JU objectives and scientific priorities

https://www.imi.europa.eu/apply-funding/future-topics

mercredi 24 juin 2020

Equipes FRM 2021

La Fondation pour la recherche médicale soutient, jusqu'à 450 000€, une quarantaine de projets de recherche biologiques aux applications potentielles en santé.

Date limite de candidature : 24 juin 2020.

https://www.frm.org/upload/chercheurs/pdf/ao_equipes_frm2021.pdf

https://www.frm.org/chercheurs/appel-a-projets-frm/espoirs-de-la-recherche

jeudi 25 juin 2020

Funding opportunities from International Foundations

On this page discover the funding opportunities of international foundations according to your activity topics

Below the exel version

lundi 29 juin 2020

NIH Funding Opportunities

NIH Funding Opportunities (Foreign Institutions are eligible to apply) / Financements NIH ouverts aux institutions non-US

Ensemble d'appels d'offres ouverts aux institutions non-US, on this page, a set of calls for proposals that are open to non-US institutions

vendredi 10 juillet 2020

Alzheimer Drug Discovery Foundation: Neuroimaging and CSF Biomarker Development RFP

The aim of this RFP is to develop biomarkers for which there is a clear clinical need in Alzheimer's disease and related dementias.

• Specifically, this RFP focuses on:
• developing novel PET ligands for clinical use
• supporting novel CSF biomarkers
• validating established MRI approaches in larger cohorts

Peripheral biofluids and digital approaches are supported through the Diagnostics Accelerator RFP.

Novel biomarkers of neuroinflammation and synaptic integrity are considered high priority. Other target areas of interest include:

• Neuronal loss
• Vascular injury and blood-brain barrier integrity
• Mitochondria and metabolic function
• Protein misfolding/proteostasis
• Oxidative stress
• White matter changes
  
  

Other novel targets supported by compelling biological rationale and connection to disease

The ADDF has limited interest in CSF measures of amyloid and tau.

Deadlines:

Average Award:

Up to $600,000 based on stage and scope of research.

Average Duration:

One year with potential for follow-on funding.
Multi-year proposals can be considered.

Funding priorities:

The ADDF focuses on supporting drug development for Alzheimer’s and related dementias and the biomarker tools that aid in this process. This RFP prioritizes biomarker programs that define a specific use and have potential for commercial and clinical translation, with an emphasis on clinical trials. The RFP supports advancement of neuroimaging and CSF biomarkers that can do one or more of the following:

Demonstrate target engagement for novel therapeutics

Detect signs of disease earlier and monitor progression

More accurately diagnose and distinguish between dementia subtypes

https://www.alzdiscovery.org/research-and-grants/funding-opportunities/biomarkers

vendredi 31 juillet 2020

Financial support to the organization of scientific events

More information : please download the document

samedi 01 août 2020

The Focused Ultrasound Foundation

We fund high risk or clinically based investigator-initiated projects through the External Awards Program. We also fund projects in high-priority applications of FUS through the Brain Program, Cancer Immunotherapy Program, and Veterinary Program, including both invited and investigator-initiated projects.

Brain program: It is the ultimate goal of the Foundation's Brain Program to see focused ultrasound become a standard of care for the treatment of a range of neurological disorders, including movement disorders, brain tumors, epilepsy and stroke.

The External Awards Program provides funding for investigator-initiated clinical, preclinical, and early-stage research projects through a competitive peer-reviewed application process.

The program has two tracks:

* The Pre-Clinical Track is geared primarily towards preclinical studies and research projects that target a particular clinical indication or organ. It is meant to fund research that could lead the way to a new reimbursable clinical application for image-guided FUS within five to seven years.

*The High-Risk Track is intended for early-stage, high-risk, proof-of-concept research that, if successful, could have a profound impact on the field of focused ultrasound and that could change the way many conditions are treated.

**Additionally, the External Awards Program accepts abstracts for Clinical Trial funding requests. The abstract form for Clinical Trials is linked in the Materials section below. Funding for clinical trials is not limited to $100,000 and one year.

Funding: one-year awards totaling approximately $100,000

The Pre-Clinical Track typically does not fund large capital purchases, cannot fund overhead or institutional expenses, and will not fund the development of new focused ultrasound equipment

Application Process

Step 1: A one-page Research Abstract must be submitted at least two weeks prior to the program’s quarterly application deadlines (Feb. 1, May 1, Aug. 1, and Nov. 1).

Step 2: The Foundation will invite full Research Proposals from authors of approved Research Abstracts.

Funding decisions are returned to the applicant approximately three months after their application deadline.

https://fusfoundation.org/for-researchers/external-research-awards-program/apply-for-funding

https://fusfoundation.org/for-researchers/external-research-awards-program

Questions?

Please contact Matt Eames, PhD, Director of External Research, at meames@fusfoundation.org.

lundi 14 septembre 2020

Interventions, services et politiques favorables à la santé

L'Institut de recherche en santé publique et ses partenaires lancent leur appel à projets 2020.

Date limite de candidature : 14 septembre 2020.

https://www.iresp.net/financements/appel-a-projets-general-2020/

lundi 14 septembre 2020

Fédération pour la Recherche sur le Cerveau : Appel à projets exceptionnel 2021 « Rotary- Espoir en Tête » 2021

La Fédération pour la Recherche sur le Cerveau lance son appel à projets exceptionnel visant à soutenir des projets de recherche portant sur des questions générales en neurosciences, ou en relation avec les pathologies neurologiques ou psychiatriques.

Cet appel à projets est organisé à l’occasion de l’opération “Rotary – Espoir en Tête 2021 ” dans le cadre du partenariat entre la FRC et les Rotariens français. Il servira exclusivement à financer ou cofinancer l’achat d’un équipement important (soit un appareil unique, soit une somme de matériels constituant un appareil unique) pouvant faire l’objet d’une utilisation commune à plusieurs équipes (mutualisation de moyens). Dans les cas de co-financements, les apports provenant d’autres sources (non liées à l’opération “Rotary – Espoir en tête”) ne devront en aucun cas excéder 20% du montant total du prix d‘acquisition du matériel. Plusieurs projets, pour des montants compris entre 80 000€ et 200 000€ chacun, pourront être financés dans le cadre du présent appel à projets. Ils pourront être présentés par une ou plusieurs équipes souhaitant poursuivre ou entreprendre une collaboration.

Procédure de candidature :

Phase 1 : Soumission du dossier d’intention (email et papier) avant le vendredi 13 mars 2020 à minuit (cachet de la poste faisant foi).

Phase 2 : Les candidatures présélectionnées présenteront un projet détaillé. Ce dossier devra parvenir à la FRC (email et papier) au plus tard le 14 septembre 2020 à minuit.

https://www.frcneurodon.org/informer-sur-la-recherche/appels-a-projet-en-cours/candidater/?cn-reloaded=1

dimanche 20 septembre 2020

France Parkinson : Grand appel d'offres exceptionnel

FRANCE PARKINSON met au concours des projets multicentriques dans le but de permettre à des équipes de réaliser de grands projets collaboratifs cliniques et/ou translationnels impliquant plusieurs sites et/ou pays et/ou disciplines. Un site français porteur du projet sera indispensable.

Cette dotation favorisera les recherches concernant l’étiologie, la physiopathologie, l’évolution, le traitement et la prise en charge de la maladie de Parkinson.

Les demandes de financement devront être comprises en 100 000 et 500 000€.

Les fonds pourront couvrir :

• Les frais de fonctionnement.
• Rémunération ou Salaire [au maximum 30% du montant total demandé].
• L’achat d’équipement nécessaire à la recherche [au maximum 10% du montant total demandé].
• Les frais de mission ET de publication [au maximum 10% du montant total demandé].

La durée du projet sera limitée à 3-5ans. Les dossiers devront être soumis exclusivement en anglais pour en faciliter l’expertise internationale.

Date limite de réception des lettres d’intention : 17 mars 2020

Réception des dossiers complets : 20 septembre 2020                                                

https://www.franceparkinson.fr/wp-content/uploads/2020/01/APPEL-A-PROJETS-GAO-2020.pdf

lundi 28 septembre 2020

American Epilepsy Society (AES): Seed Grant for established investigators

In partnership with our rare disease partners offer seed funding to help established investigators launch new lines of research, collaborations, and/or research methods.

Seed grants provide up to $20,000 for one year, to be used to cover direct costs to fund preliminary investigation that will help researchers compete for larger grants that cover the full cost of research. They may not be renewed.

Current Round Deadlines:

April 3, 2020.

September 28, 2020

Eligibility Criteria: Preference will be given to applications for research to be conducted at U.S. institutions. Depending on available funds, applications may be considered from investigators outside the U.S. who otherwise meet the eligibility criteria.

https://www.aesnet.org/research/funding%20for%20established%20investigators/seed_grant_program

mercredi 30 septembre 2020

ARSEP: Working Visits

To facilitate exchanges between clinical centres and/or laboratories involved in MS. Travel may be within, to, or from France.

• The training period can be up to 6 months.
• Funding requests for up to 6.000 € to cover travel and accommodation are permitted.

Deadline: No deadline - throughout the year

https://www.arsep.org/fr/220-calls-for-proposals.html

https://www.arsep.org/library/media/other/Scientifique/Regulation-Working-visits-Travel-Grants-website.pdf

jeudi 03 décembre 2020

The American Parkinson Disease Association (APDA): Research Grants: Academic Year 2020-2021

Award:

One year grants up to a maximum of $75,000 will be awarded to research scientists (MD, MD/PhD, or PhD). The same investigator can reapply the following year to be considered for a second consecutive year of funding.

Goal:

APDA Research Grants are intended to support basic or applied research aimed at reducing the burden of Parkinson’s disease.  The APDA seeks to promote the entry of new investigators in to the field of Parkinson research, as well as to support important new ideas in the field worthy of investigation.

Eligibility:

All research scientists in the field of Parkinson’s research can apply, but the selection committee will more favorably consider researchers who are new to the field of Parkinson’s disease.

Deadline: 03/12/2020

Funding is not to be used for:

    Indirect costs.

    Institutional overhead.

    Salary for the principal investigator higher than $50,000.

    Travel expenses.

    Publication costs higher than $1,000.

    Equipment costs higher than $8,000.

https://www.apdaparkinson.org/research/research-opportunities/grants/

https://www.apdaparkinson.org/research/

vendredi 01 janvier 2021

European Brain Research Area consortium (EBRA): Call for clusters

The EBRA consortium is launching a Call for Clusters to promote co-operation and exchange between brain research projects and networks, and thus enable or enhance international collaboration and the emergence of development of clusters in all areas of brain research.

A cluster is understood as an association of research projects that can be directed towards basic research, clinical research and/or methodological approaches under a common topic, and disease and/or thematic area.

The individual members of a cluster application should be complementary.

The cluster formation should lead to a step-wise change in the landscape of that research area and should demonstrate a clear added-value in the collaboration/cooperation over individual projects including, but not limited to, sharing of resources (models, databases, diagnostics etc.), harmonisation of data, sharing of specific know-how and/or innovative technologies, etc.

The EBRA call for cluster is an open call until 1 January 2021.

Deadlines

1 June 2019
1 January 2020
1 June 2020
1 January 2021

More information: https://www.ebra.eu/Call4Clusters/